Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-13-006895
Filing Date
2013-11-26
Accepted
2013-11-26 15:37:04
Documents
2
Period of Report
2013-12-02
Effectiveness Date
2013-11-26

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1113_actinium.htm DEF 14A 1136474
2 logo.jpg GRAPHIC 19764
  Complete submission text file 0001213900-13-006895.txt   1164929
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-52446 | Film No.: 131244041
SIC: 6770 Blank Checks